Respiratory Syncytial Virus

The Pharmacy Times® Respiratory Syncytial Virus Resource Center is a comprehensive source for clinical news and expert insights on treating and preventing respiratory syncytial virus.

Latest News

RSV vaccine vial with syringe -- Image credit: MargJohnsonVA | stock.adobe.com
FDA Accepts Priority Review Application for RSV Vaccine to Prevent Illness in Adults

February 12th 2024

The updated indication for the respiratory syncytial virus vaccine is for adults aged 50 to 59 with underlying conditions who are at an increased risk of contracting the virus.

Understand RSV Treatment Options in Adults
Understand RSV Treatment Options in Adults

February 8th 2024

Research Develops Key Points to Address RSV Vaccine Hesitancy in Older Adults
Research Develops Key Points to Address RSV Vaccine Hesitancy in Older Adults

February 6th 2024

Considerations for RSV Prevention in Special Patient Populations
Considerations for RSV Prevention in Special Patient Populations

February 2nd 2024

Blood collection tubes Respiratory syncytial virus(RSV) test positive results,medical concept - Image credit: JUN LI | stock.adobe.com
Researchers Highlight Need for Greater Research Into RSV Among Older Adults, Vaccine Management

February 1st 2024

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.